UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 423

Sortiert nach

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

Journal of diabetes investigation, 2013-03, Vol.4 (2), p.108-130

2013

Link zum Volltext

Verfügbarkeit prüfen

ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue

Frontiers in endocrinology (Lausanne), 2020-12, Vol.11, p.587189-587189

2020

Link zum Volltext

Verfügbarkeit prüfen

Dietary and Nutritional Guidelines for People with Diabetes

Nutrients, 2023-10, Vol.15 (20), p.4314

2023

Link zum Volltext

Verfügbarkeit prüfen

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

Journal of diabetes investigation, 2016-04, Vol.7 (S1), p.102-109

2016

Link zum Volltext

Verfügbarkeit prüfen

The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer of β-Cell Proliferation

Journal of diabetes research, 2016-01, Vol.2016, p.4860595-7

2016

Link zum Volltext

Verfügbarkeit prüfen

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Journal of diabetes investigation, 2010-02, Vol.1 (1‐2), p.8-23

2010

Link zum Volltext

Verfügbarkeit prüfen

Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in Japan: Post hoc analysis of the LixiLan JP‐O2 trial

Diabetes, obesity & metabolism, 2021-12, Vol.23 (12), p.2795-2803

2021

Link zum Volltext

Verfügbarkeit prüfen

Carotid Intima-Media Thickness and Visit-to-Visit HbA1c Variability Predict Progression of Chronic Kidney Disease in Type 2 Diabetic Patients with Preserved Kidney Function

Journal of Diabetes Research, 2016-01, Vol.2016, p.3295747-6

2016

Link zum Volltext

Verfügbarkeit prüfen

Incretin actions beyond the pancreas: lessons from knockout mice

Current opinion in pharmacology, 2013-12, Vol.13 (6), p.946-953

2013

Link zum Volltext

Verfügbarkeit prüfen

Japanese Clinical Practice Guideline for Diabetes 2016

Journal of diabetes investigation, 2018-05, Vol.9 (3), p.657-697

2018

Link zum Volltext

Verfügbarkeit prüfen

The Role of Metagenomics in Precision Nutrition

Nutrients, 2020-06, Vol.12 (6), p.1668

2020

Link zum Volltext

Verfügbarkeit prüfen

Species-Related Differences in the Proteome of Rat and Human Pancreatic Beta Cells

Journal of Diabetes Research, 2015-01, Vol.2015, p.549818-11

2015

Link zum Volltext

Verfügbarkeit prüfen

Psychometric Properties of a Moroccan Version of the Summary of Diabetes Self-Care Activities Measure

Journal of Diabetes Research, 2016-01, Vol.2016, p.5479216-6

2016

Link zum Volltext

Verfügbarkeit prüfen

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes

Journal of diabetes investigation, 2023-01, Vol.14 (1), p.151-164

2023

Link zum Volltext

Verfügbarkeit prüfen

Japanese Clinical Practice Guideline for Diabetes 2016

Diabetology international, 2018-02, Vol.9 (1), p.1-45

2018

Link zum Volltext

Verfügbarkeit prüfen

Advances in insulin therapy from discovery to β‐cell replacement

Journal of diabetes investigation, 2023-01, Vol.14 (1), p.15-18

2023

Link zum Volltext

Verfügbarkeit prüfen

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology

Journal of diabetes investigation, 2019-09, Vol.10 (5), p.1168-1170

2019

Link zum Volltext

Verfügbarkeit prüfen

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity

Journal of diabetes investigation, 2019-07, Vol.10 (4), p.902-905

2019

Link zum Volltext

Verfügbarkeit prüfen

Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15842

2023

Link zum Volltext

Verfügbarkeit prüfen

Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes

Journal of diabetes investigation, 2024-01, Vol.15 (1), p.63-66

2024

Link zum Volltext

Verfügbarkeit prüfen

SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient with Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two Drug Classes

Internal Medicine, 2020/06/15, Vol.59(12), pp.1535-1539

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of the angiotensin receptor‐neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls

Journal of diabetes investigation, 2023-09, Vol.14 (9), p.1038-1040

2023

Link zum Volltext

Verfügbarkeit prüfen

Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report

Endocrine Journal, 2022, Vol.69(4), pp.473-477

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index

Journal of diabetes investigation, 2022-07, Vol.13 (7), p.1161-1174

2022

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based practice guideline for the treatment for diabetes in Japan 2013

Diabetology international, 2015-09, Vol.6 (3), p.151-187

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 423

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(339)
Mit Volltextzugriff
(413)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(386)
Japanisch
(138)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(261)
Life Sciences & Biomedicine
(238)
Humans
(140)
Endocrinology & Metabolism
(139)
Diabetes
(110)
Male
(81)
Type 2 Diabetes
(81)
Diabetes Mellitus
(78)
Glucose
(72)
Female
(68)
Insulin
(63)
Animals
(51)
Middle Aged
(50)
Aged
(47)
Glucagon
(39)
Mice
(38)
Diabetes Mellitus, Type 2 - Drug Therapy
(36)
Adult
(35)
Japan
(35)
Patients
(34)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas

ChREBP-Mediated Regulation of Lipid Metabolism: Involvement of the Gut Microbiota, Liver, and Adipose Tissue

Dietary and Nutritional Guidelines for People with Diabetes

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer of β-Cell Proliferation

GIP and GLP‐1, the two incretin hormones: Similarities and differences

Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in Japan: Post hoc analysis of the LixiLan JP‐O2 trial

Carotid Intima-Media Thickness and Visit-to-Visit HbA1c Variability Predict Progression of Chronic Kidney Disease in Type 2 Diabetic Patients with Preserved Kidney Function

Incretin actions beyond the pancreas: lessons from knockout mice

Japanese Clinical Practice Guideline for Diabetes 2016

The Role of Metagenomics in Precision Nutrition

Species-Related Differences in the Proteome of Rat and Human Pancreatic Beta Cells

Psychometric Properties of a Moroccan Version of the Summary of Diabetes Self-Care Activities Measure

A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes

Japanese Clinical Practice Guideline for Diabetes 2016

Advances in insulin therapy from discovery to β‐cell replacement

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology

Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity

Glucokinase Variant Proteins Are Resistant to Fasting-Induced Uridine Diphosphate Glucose-Dependent Degradation in Maturity-Onset Diabetes of the Young Type 2 Patients

Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes

SGLT2 Inhibitor and GLP-1 Receptor Agonist Combination Therapy Substantially Improved the Renal Function in a Patient with Type 2 Diabetes: Implications for Additive Renoprotective Effects of the Two Drug Classes

Impact of the angiotensin receptor‐neprilysin inhibitor in clinical diabetes management: Potential benefits and pitfalls

Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index

Evidence-based practice guideline for the treatment for diabetes in Japan 2013

Suchergebnisse filtern